Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
Mallinckrodt
Merck
Colorcon

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: MINOCYCLINE HYDROCHLORIDE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

MINOCYCLINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-330-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05)
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-330-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-30)
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-330-69 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (10631-330-69)
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-331-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-331-05)
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-331-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-331-30)
Sun Pharm Inds Inc XIMINO minocycline hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 201922 NDA Sun Pharmaceutical Industries, Inc 10631-331-69 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (10631-331-69)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Medtronic
AstraZeneca
Express Scripts